[Federal Register: December 13, 1999 (Volume 64, Number 238)] [Notices] [Page 69538] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr13de99-84] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public. Name of Committee: Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues. Date and Time: The meeting will be held on December 15, 1999, 9 a.m. to 4:30 p.m. Location: Corporate Bldg., conference room 20B, 9200 Corporate Blvd., Rockville, MD. Contact Person: Michelle Y. Stuart, Center for Devices and Radiological Health (HFZ-440), Food and Drug Administration, 2098 Gaither Rd., Rockville, MD 20850, 301-594-1293, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12515. Please call the Information Line for up-to-date information on this meeting. Procedure: On December 15, 1999, from 9 a.m. to 10 a.m., the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by December 13, 1999. Those desiring to make formal oral presentations should notify the contact person by December 13, 1999, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. Time allotted for the presentations may be limited. Closed Committee Deliberations: On December 15, 1999, from 10 a.m. to 4:30 p.m., the meeting will be closed to the public. The committee will hear and review trade secret and/or confidential commercial information on a product development protocol (5 U.S.C. 552b(c)(4)). This portion of the meeting is closed to permit discussion of this information. FDA regrets that it was unable to publish this notice 15 days prior to the December 15, 1999, Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee meeting. Because the agency believes there is some urgency to bring this issue to public discussion and qualified members of the Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee were available at this time, the Commissioner concluded that it was in the public interest to hold this meeting even if there was not sufficient time for the customary 15-day public notice. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: December 7, 1999. Linda A. Suydam, Senior Associate Commissioner. [FR Doc. 99-32239 Filed 12-8-99; 4:55 pm] BILLING CODE 4160-01-F